These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32840130)

  • 1. 1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in
    Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Dei S; Teodori E
    Future Microbiol; 2020 Jul; 15():987-999. PubMed ID: 32840130
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
    J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli.
    Sugawara E; Nikaido H
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7250-7. PubMed ID: 25246403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli.
    Hirakawa H; Takumi-Kobayashi A; Theisen U; Hirata T; Nishino K; Yamaguchi A
    J Bacteriol; 2008 Sep; 190(18):6276-9. PubMed ID: 18567659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance.
    Swick MC; Morgan-Linnell SK; Carlson KM; Zechiedrich L
    Antimicrob Agents Chemother; 2011 Feb; 55(2):921-4. PubMed ID: 21098250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated Beta-diketo Phosphorus Ylides Are Novel Efflux Pump Inhibitors in Bacteria.
    Kincses A; Szabó ÁM; Saijo R; Watanabe G; Kawase M; Molnár J; Spengler G
    In Vivo; 2016 11-12; 30(6):813-817. PubMed ID: 27815466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.
    Elkins CA; Nikaido H
    J Bacteriol; 2002 Dec; 184(23):6490-8. PubMed ID: 12426336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
    Bohnert JA; Schuster S; Kern WV; Karcz T; Olejarz A; Kaczor A; Handzlik J; Kieć-Kononowicz K
    Antimicrob Agents Chemother; 2016 Apr; 60(4):1974-83. PubMed ID: 26824939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in
    Tambat R; Mahey N; Chandal N; Verma DK; Jangra M; Thakur KG; Nandanwar H
    ACS Infect Dis; 2022 Feb; 8(2):255-270. PubMed ID: 35045260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
    Misra R; Morrison KD; Cho HJ; Khuu T
    J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
    Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
    Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
    Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
    J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance.
    Hobbs EC; Yin X; Paul BJ; Astarita JL; Storz G
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16696-701. PubMed ID: 23010927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
    Vediyappan G; Borisova T; Fralick JA
    J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
    Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.